Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04211194 · ClinicalTrials.gov registry record
Registry for Upper Gastrointestinal Bleeding
A clinical trial of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage, sponsored by AdventHealth.
- Completed
- Registry status
- 2,999
- Enrollment target
- 1
- Study location
NCT04211194 is a study of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage that has completed, run by AdventHealth. The registered enrollment target is 2,999 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04211194, a study of Peptic Ulcer Hemorrhage and Peptic Ulcer, Acute With Hemorrhage, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- 2,999 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
Conditions Studied
Interventions
- PROCEDURE Upper GI Endoscopy
Study Locations (1)
Florida
- Center for Interventional Endoscopy - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,999 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04211194
The ClinicalTrials.gov registry entry for NCT04211194 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,999 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peptic Ulcer Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Upper GI Endoscopy is the first listed.
NCT04211194 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04211194 about?
NCT04211194 is a clinical study titled "Registry for Upper Gastrointestinal Bleeding". This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
What is the current status of trial NCT04211194?
This trial is currently completed. The enrollment target is 2,999 participants. The study started on 2019-10-01. Estimated completion is 2021-01-31.
What conditions does trial NCT04211194 study?
This clinical trial studies the following conditions: Peptic Ulcer Hemorrhage, Peptic Ulcer, Acute With Hemorrhage.
What interventions are being tested in trial NCT04211194?
The interventions under investigation include: Upper GI Endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT04211194?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04211194 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peptic Ulcer Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.